bioMérieux Reaffirms 2026 Organic Sales Growth Forecast of 3%-5%
- bioMérieux reaffirmed its 2026 organic sales growth forecast of 3%-5%.
- Contributive operating income before non-recurring items is expected to grow 0%-10% organically.
- The expected currency drag on operating income narrowed to €35 million from €40 million-€50 million previously.
- The sales forecast’s lower end assumes fourth-quarter respiratory epidemiology matches the same period in 2025.
- Third-quarter sales rose 8.1% organically to €1.04 billion, supported by 13% growth across GO•28 strategic growth drivers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMérieux SA published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.